Share Price, page-9151

Absolutely spot on!!

I posted about this some time ago as per the information below:

Pre PMS= $17
Post PMS= $21

Pre PH(midyear which includes 2 further quarters of revenue growth) = $23
Post PH= $27

Pre AM(midyear which includes 2 further quarters of revenue growth) = $27
Post AM= $35

At this point I am beginning to apply a significant multiplier effect given the 3 previous successful P2 trials

Pre PW(End of year which includes 2 further quarters of revenue growth) - $40
Post PW- $50

It appears I was wrong on the downside following PMS and we have reached much higher ($25).

Good financials next week will push us back to $25 in my view and we will hover until late April or early May, at which point we will have another quarter of revenue and Pitt Hopkins results. I think once we get to post Angelamn (presuming they are all positive) then I think we will see significant uplift and we will end up pushing past $50 post Prader Willi - I think we will edge closer to $60.

Why on earth would anyone in management sign off on $40 now when we will easily and organically get there by July - in my opinion.

Makes no sense to me.